MAR002 is an early, promising development: a new take on a proven strategy, with the potential for stronger IGF-1 control and dramatically less frequent dosing. At the same time, it’s important to keep expectations grounded. The drug is still investigational. It is not approved, not yet available outside clinical trials, and a larger patient study is needed to confirm what the early data suggest.
From Lewis S Blevins, Jr. MD – Pathologists are the mystery men and women behind the scenes in your healthcare. You will never meet them. You might see their name on a report or two
Media Release – From the International Congress of Endocrinology/ European Congress of Endocrinology High-pitched sound raises the stress hormone cortisol while low-pitched sound reduces it according to a small pilot study presented at the joint
From Lewis S. Blevins Jr., MD – Hyperplasia is an increase in the number of cells in a tissue. The cells are related, in that they may be of the same cell type, but are
From Lewis S Blevins Jr., MD – TSH-secreting (thyrotroph) adenomas are rare and account for less than 1% of all pituitary adenomas. They usually lead to excess production of thyroid hormone (hyperthyroidism), but can also
From Lewis S Blevins Jr., MD – The vast majority of patients with hypothyroidism can be treated with l-T4 and achieve relief of symptoms of hypothyroidism and normal T4 and T3 levels. The liver and
From Lewis S Blevins Jr., MD – There is controversy as to how to treat patients with partial hypothyroidism due to pituitary disorders and even primary hypothyroidism. After a quarter of a century of practice,
Here are a few highlights from the California Center for Pituitary Disorders at the University of California San Francisco, UCSF annual Pituitary Update Conference : Only 60% of patients with pituitary macroadenomas and vision loss have
From Lewis S Blevins Jr,. MD – My approach to the postoperative evaluation of patients with acromegaly is based on over a quarter of a century of experience evaluating and treating patients with the disorder.
We promote traditional approaches to pituitary disorders. We believe in ongoing research and development to expand knowledge and discover new therapies. We recognize that most medications have, as their point of origin, some derivation from
From Lewis S Blevins, Jr. MD – All too often, I see patients who come to the clinic with devastating recurrences of their pituitary tumors. For example, the accompanying MRI depicts a recurrent pituitary tumor in
From Lewis S Blevins Jr., MD – Although dopamine agonist drugs are available to treat prolactinomas I believe some patients with these tumors are probably best treated surgically. Of course, surgery should be performed by
First, I know “think different” is bad grammar as it should be “think differently”, but it really says it, doesn’t it? A few years ago, 1998 to be exact, Apple, Inc., (the then computer company)